
In a historic move for agricultural biotechnology, the U.S. Food and Drug Administration (FDA) has granted regulatory approval for the use of gene-edited…..
The U.S. Food and Drug Administration (FDA) has officially approved Penpulimab, a humanized monoclonal antibody targeting PD-1 for the treatment of recurrent…
The U.S. Food and Drug Administration (FDA) has officially approved a ready-to-dilute multi-dose vial formulation of thiotepa for the treatment of breast….
In a historic move that underscores the growing potential of gene-based therapies, the U.S. Food and Drug Administration (FDA) has approved Zevaskyn…..
Theralase Technologies Inc., a Toronto-based clinical-stage pharmaceutical company, has announced a significant advancement in understanding the…..